Effect of daridorexant on nighttime wakefulness and next-morning sleepiness: assessing the transition from night to day in insomnia disorder
Daridorexant reduces wakefulness throughout the entire night while independently decreasing morning sleepiness and improving daytime functioning and alertness.
Authors
- Pierre‐Philippe Luyet
- Gary Zammit (ORCID: https://orcid.org/0000-0001-8332-6687)
- Guy Braunstein
- Yves A Dauvilliers (ORCID: https://orcid.org/0000-0003-0683-6506)
- Antonio Olivieri (ORCID: https://orcid.org/0000-0002-9198-6834)
Institutions
- Inserm (FR)
- Université de Montpellier (FR)
- Clinilabs (United States) (US)
- Institute for Neurosciences of Montpellier (FR)
- Idorsia (Switzerland) (CH)
- Actelion (Switzerland) (CH)
Publication Details
- Journal
- Sleep Medicine
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.sleep.2025.106523
- Citations
- 2
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Idorsia Pharmaceuticals